Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0D5ZX
|
||||
| Former ID |
DIB014945
|
||||
| Drug Name |
RG-12915
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Nausea [ICD10:R11] | Discontinued in Phase 3 | [1] | ||
| Company |
Rhone-Poulenc SA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H25ClN2O2
|
||||
| Canonical SMILES |
c12c(C(=O)N[C@@H]3CN4CCC3CC4)cc(cc1[C@H]1[C@@H](O2)CCCC<br />1)Cl
|
||||
| CAS Number |
CAS 136174-04-4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Antagonist | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001786) | ||||
| REF 2 | Cataractogenesis in rats induced by in utero exposure to RG 12915, a 5-HT3 antagonist. Fundam Appl Toxicol. 1995 Sep;27(2):270-6. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.